DF.PR.A
$5.73
8.318%

Verve Therapeutics Inc.
Key Data

Last updated: Jun 6, 2025, 1:36 AM ET

Price Metrics  

  • Open
    5.30
  • Close
    5.73
  • Prev. Close
    5.29
  • Day High/Low
    6.18/5.18
  • 52 Week High/Low
    9.305/2.865
  • Alpha
    -0.034
  • Beta
    1.675
  • VWAP
    5.777

Moving Averages  

  • 21 Day Moving Average
    4.518
  • 50 Day Moving Average
    4.584
  • 200 Day Moving Average
    5.669

Valuation Metrics  

  • Market Cap (All Classes)
    510,790,749.00
  • Market Cap
    510,790,749.00
  • EPS (TTM)
    —
  • P/E Ratio (TTM)
    —
  • P/B Ratio
    1.00
  • P/CF Ratio
    -4.20
  • D/E Ratio
    0.14
  • Return on Equity
    -34.26%
  • Return on Assets
    -26.89%

Share Statistics  

  • Total Shares (All Classes)
    89,143,237.00
  • Listed Shares Outstanding
    89,143,237.00
  • Escrow Shares
    —
  • Volume
    6,957,124.00
  • 10 Day Avg Vol.
    3,377,904.00
  • 20 Day Avg Vol.
    3,131,695.00
  • 30 Day Avg Vol.
    2,927,221.00
  • 50 Day Avg Vol.
    3,922,983.00

Dividends  

  • Dividend
    —
  • Dividend Frequency
    —
  • Dividend Yield (Ann)
    —
  • Ex-Date
    —
  • Payable date
    —
  • Dividend Growth (3 Year)
    —
  • Dividend Growth (5 Year)
    —

Short Interest (as of Jun 6, 2025)  

  • Short Interest as % of Float
    -%
  • Short Interest Days to Cover
    -
Want more in-depth company research in real-time?
Learn more about TMX Powerstream today.